Progression of renal failure in the Han: SPRD polycystic kidney rat

• Published in: Nephrology, dialysis, transplantation dialysis, transplantation, 1994, Vol.9 (12), p.1734-1739
• Main Authors: Zeier, M., Pohlmeyer, G., Deerberg, F., Schönherr, R., Ritz, E.
• Format: Article
• Language: English
• Subjects: ACE inhibitors; Han: SPRD Pkd; polycystic kidney disease; progression of renal failure; sex hormones; uninephrectomy
• ISSN: 0931-0509; 1460-2385
• DOI: 10.1093/oxfordjournals.ndt.a092754

The Han: SPRD Pkd rat mutant is an autosomal dominant rat model with incomplete penetration of polycystic renal transformation. Progressive renal failure occurs in heterozygous male animals. The mechanisms of progression have not been elucidated. To identify some pathogenetic factors involved we subjected male SPRD Pkd rats (and their non-affected littermates as controls) to uninephrectomy (UNX), castration or enalapril treatment. To assess progression S-urea at age 150 days was chosen as endpoint. (i) In uninephrectomized male Han: SPRD Pkd (n=12 animals per group) S-urea at age 150 days was consistently above 300 mg/dl, while it was 245 mg/dl (191–290) in control Han: SPRD Pkd. (ii) In castrated male Han: SPRD median S urea at 150 days was 100 mg/dl (69–211) compared to sham-operated male Han: SPRD controls (245; 191–290). Castration did not, however, prevent accelerated progression after uninephrectomy. (iii) Enalapril (50 mg/l) in the drinking fluid did not significantly lower median systolic blood pressure (by plethysmography) in animals on 0.2% sodium diet (at 185 days 160 mmHg; 140–170 versus 170; 140–195 in non-enalapril controls), although circulating ACE was significantly inhibited (17 U; 11–33 versus 89; 52–108 in controls). S-urea at age 185 days was not significantly different in the 2 groups. In conclusion, the Han: SPRD Pkd model differs from human ADPKD to some extent. Uninephrectomy accelerates renal failure in the rat, but not in humans. On the other hand, in contrast to human ADPKD the renin system is suppressed in the rat model and ACE inhibition does not affect the course of renal failure.